"Every sucess is the mother of countless others"

Henry Ford

In-/Out-Licensing

Natural surfactant for prevention and treatment of IRDS

Natural surfactant for the treatment of RDS

Active ingredient

- Phospholipid fraction from bovine lungs

Use

- Prevention of respiratory distress syndrome (RDS) in premature infants

- Treatment of infantile respiratory distress syndrome (IRDS)

Pharmaceutical form and presentations

- Lyophilized phospholipids in vials with 50 mg and 100 mg

- Syringe with solvent for reconstitution

Application

- Intratracheal instillation

Special feature

- Storage at room temperature

Produced in

- European Union

Available countries

- On request

 

Regulatory status, indications and product information may vary from country to country.

Product descriptions provide basic information and are not usage instructions.

Please observe the officially approved product information.

Diese Website verwendet ausschließlich technisch notwendige Cookies. Read more …